Improving Minority Health in Rheumatic Disease (IMHeaRD)
改善少数民族风湿病健康 (IMHeaRD)
基本信息
- 批准号:10488452
- 负责人:
- 金额:$ 16.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-25 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:Administrative SupplementAdvisory CommitteesAdvocacyAdvocateAppointmentAreaAvena sativaAwarenessBlack raceBusinessesClinicalClinical ResearchCollaborationsCollectionCommunicationCommunitiesConflict of InterestDataDiagnosisEffectivenessEnsureEthnic groupEvaluationFacultyFosteringFoundationsFundingGoalsGrantHealthHealth ProfessionalHuman ResourcesIndividualInfrastructureInvestigationKnowledgeLeadLeadershipLupusMeasuresMedicalMentorsMethodologyMissionMonitorMorbidity - disease rateNational Institute of Arthritis and Musculoskeletal and Skin DiseasesOutcomeOutputPatientsPerformancePilot ProjectsPreventionPrevention strategyProblem SolvingProductivityRaceReportingResearchResearch ActivityResearch InstituteResearch PersonnelResource SharingResourcesRheumatismRiskSamplingScientistSclerodermaServicesSeveritiesSouth CarolinaSystemic Lupus ErythematosusSystemic SclerodermaTimeTranslational ResearchTravelUnited StatesUniversitiesUpdateblack patientclinical careclinical centerdesignexperiencefollow-uphealth care availabilityhealth disparityimprove minority healthimprovedinnovationmeetingsminority investigatormortalityoperationoutreachprogramsracial disparityshared databaseskillstoolweb sitewomen faculty
项目摘要
Project Summary – Administrative Core
The Administrative Core of the Core Center for Clinical Research (CCCR) for Improving Minority Health in
Rheumatic Diseases (IMHeaRD) at the Medical University of South Carolina provides leadership and
management for the center and a pilot projects program that is funded entirely with institutional commitments.
The mission of this CCCR is to advance knowledge with respect to the clinical care and health outcomes of Black
patients who have, or who are at risk of developing, systemic lupus erythematosus, scleroderma and other
debilitating rheumatic diseases. The overarching goals of the Administrative Core are to: (a) ensure the quality,
validity, accessibility and applicability of the tools, services, samples, data and other output of the CCCR cores,
(b) foster interactions among basic, translational and clinical scientists at MUSC and beyond to focus effectively
on prevention, diagnosis and treatment of rheumatic diseases, (c) facilitate appropriate dissemination of research
results and resources, and (d) establish/continue collaborations with other CCCRs/CORTS to share best
practices, methodology and unique skills. To achieve these goals, we will pursue the following specific aims: 1.
Provide leadership for the CCCR; 2. Coordinate and manage CCCR organizational, operational and financial
functions and evaluative activities; 3. Leverage institutional infrastructure resources; 4. Conduct a multi-year
Evaluation Plan; 5. Strengthen and expand robust communication, dissemination and outreach activities,
fostering mutually productive interactions among health professionals, scientists and local communities; and 6.
Provide a competitive Pilot Projects Program. This core will be directed by Jim Oates, MD, with assistance from
two Associate Directors, Gary Gilkeson, MD, and Diane Kamen, MD, an Executive Committee that includes core
leaders and Research Community representatives, an Internal Advisory Committee that includes institutional
stakeholders and patient advocates, and an External Advisory Committee that includes experts in the field with
experience leading other NIAMS centers. The Administrative Core staff provides administrative support for the
center, administering and monitoring the finances, coordinating meetings and action items, and interfacing with
NIAMS staff and institutional personnel. The Administrative Core also supports educational and dissemination
activities to enhance the visibility and impact of the center within MUSC and the local community and provide a
forum for communicating and exchanging research ideas. The Administrative Core nurtures a vibrant, interactive
program of clinical and translational research to advance our knowledge and resources for improving the
prevention, diagnosis, treatment and health outcomes for rheumatic diseases, notably systemic lupus
erythematosus and systemic sclerosis, which occur significantly more often and with greater severity in Black
patients than in other racial and ethnic groups in the United States.
项目摘要 - 行政核心
临床研究核心中心(CCCR)的行政核心,用于改善少数民族健康
南卡罗来纳州医科大学的风湿病(Imheard)提供领导才能
该中心的管理和一个完全由机构承诺资助的试点项目计划。
该CCCR的任务是提高有关黑色临床护理和健康成果的知识
患者有或有发育风险的系统性红斑狼疮,硬皮病和其他患者
衰弱的风湿病。行政核心的总体目标是:(a)确保质量,
CCCR内核的工具,服务,样品,数据和其他输出的有效性,可访问性和适用性,
(b)MUSC及以后的基本,翻译和临床科学家之间的促进相互作用,以有效地关注
关于风湿性疾病的预防,诊断和治疗,(c)促进适当分发研究
结果和资源,以及(d)建立/继续与其他CCCR/CORTS合作以分享最佳
实践,方法和独特的技能。为了实现这些目标,我们将追求以下特定目标:1。
为CCCR提供领导; 2。协调和管理CCCR组织,运营和财务
功能和评估活动; 3。利用机构基础设施资源; 4。进行多年
评估计划; 5。加强和扩大强大的沟通,传播和外展活动,
促进卫生专业人员,科学家和当地社区之间相互生产的互动;和6。
提供竞争性的试点项目计划。该核心将由医学博士吉姆·奥茨(Jim Oates)指导
两名副董事,马里兰州加里·吉尔克森(Gary Gilkeson)和包括核心委员会的执行委员会
领导者和研究社区代表,内部咨询委员会,包括机构
利益相关者和患者倡导者以及一个外部咨询委员会,其中包括该领域的专家
经验带领其他Niams中心。行政核心人员为
中心,管理和监视财务,协调会议和行动项目,并与
NIAMS的工作人员和机构人员。行政核心还支持教育和传播
活动以增强中心在MUSC和当地社区内的可见性和影响,并提供
交流和交换研究思想的论坛。行政核心护士是一个充满活力的互动
临床和转化研究计划,以促进我们的知识和资源来改善
风湿性疾病的预防,诊断,治疗和健康结果,特别是全身性狼疮
红斑和全身性硬化症,发生的频率更高,黑色的严重程度更高
患者比美国其他种族和族裔群体。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES C OATES其他文献
JAMES C OATES的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES C OATES', 18)}}的其他基金
Predictive Biomarkers for disease activity and organ damage in patients with lupus
狼疮患者疾病活动和器官损伤的预测生物标志物
- 批准号:
10152359 - 财政年份:2018
- 资助金额:
$ 16.55万 - 项目类别:
Predictive Biomarkers for disease activity and organ damage in patients with lupus
狼疮患者疾病活动和器官损伤的预测生物标志物
- 批准号:
9925731 - 财政年份:2018
- 资助金额:
$ 16.55万 - 项目类别:
Predictive Biomarkers for disease activity and organ damage in patients with lupus
狼疮患者疾病活动和器官损伤的预测生物标志物
- 批准号:
10400918 - 财政年份:2018
- 资助金额:
$ 16.55万 - 项目类别:
Improving Minority Health in Rheumatic Disease (IMHeaRD)
改善少数民族风湿病健康 (IMHeaRD)
- 批准号:
10709535 - 财政年份:2017
- 资助金额:
$ 16.55万 - 项目类别:
Improving Minority Health in Rheumatic Disease (IMHeaRD)
改善少数民族风湿病健康 (IMHeaRD)
- 批准号:
10488451 - 财政年份:2017
- 资助金额:
$ 16.55万 - 项目类别:
Improving Minority Health in Rheumatic Disease (IMHeaRD)
改善少数民族风湿病健康 (IMHeaRD)
- 批准号:
10488454 - 财政年份:2017
- 资助金额:
$ 16.55万 - 项目类别:
Improving Minority Health in Rheumatic Disease (IMHeaRD)
改善少数民族风湿病健康 (IMHeaRD)
- 批准号:
10709534 - 财政年份:2017
- 资助金额:
$ 16.55万 - 项目类别:
Improving Minority Health in Rheumatic Disease (IMHeaRD)
改善少数民族风湿病健康 (IMHeaRD)
- 批准号:
10709544 - 财政年份:2017
- 资助金额:
$ 16.55万 - 项目类别:
Targeting Pathogenic Endothelial Dysfunction in Lupus Nephritis
针对狼疮性肾炎的致病性内皮功能障碍
- 批准号:
10487863 - 财政年份:2016
- 资助金额:
$ 16.55万 - 项目类别:
相似海外基金
Redefining C.difficile patient outcomes through network medicine
通过网络医学重新定义艰难梭菌患者的治疗结果
- 批准号:
10722290 - 财政年份:2023
- 资助金额:
$ 16.55万 - 项目类别:
Radiation Oncology at the Interface of Pediatric Cancer Biology and Data Science
儿科癌症生物学和数据科学交叉领域的放射肿瘤学
- 批准号:
10712290 - 财政年份:2023
- 资助金额:
$ 16.55万 - 项目类别:
Access for All in ALS (ALL ALS) West Clinical Coordinating Center
ALS 所有人 (ALL ALS) 西部临床协调中心
- 批准号:
10878596 - 财政年份:2023
- 资助金额:
$ 16.55万 - 项目类别: